seroconversion - Globe Thesis

Keyword [seroconversion] Result: 41 - 60 \| Page: 3 of 4
41.	A Meta-analysis Of Immunogenicity Of Meningococcal Vaccine Contained The Components Of Serogroup A And Serogroup C
42.	Negative Regulation Of NKG2A On CD8~+αβ T Cell Response To HBV In Chronic Hepatitis B
43.	Analysis Of The Factors Affecting The Outcome Of HBeAg Seroconversion In Antiviral Monotherapy Naive Hbeag Positive CHB Patients
44.	A Prospective Study Of Addiing On Peginterferon Therapy In Nucleoside Analogues Treated HBeAg Positive Chronic Hepatitis B Patients
45.	Changes And Significance Of T Follicular Helper Sub-group In Patients With Chronic Hepatitis B Before And After Interferon Treatment
46.	Immunological Characteristics Of Different Clinical Outcomes Of Hbeag Serology In Children With Chronic Hbv Infection And Establishment Of Gender And Age-Specific Reference Intervals For Serum Alt,Ast,Akp And Ggt In Children And Its Application In The Nat
47.	Expression And Antiviral Function Of Toll-like Receptor 7 In Chronic Hepatitis B Patients And Its Correlation With Peg-IFN-α-2a Therapy
48.	The Efficacy And Predictive Factors Of Peginterferon Alfa-2a Treatment In HBeAg Positive Chronic Hepatitis B Patients
49.	Evaluating Siglec-7 Expression As A Biomarker To Predict HBeAg Seroconversion And Sustained Virological Response Undergoing Pegylated Interferon Therapy In Chronic HBV Patients
50.	Circulating Follicular Regulatory T Cells In Chronic Hepatitis B Virus Infection
51.	The Research Of Predictive Value Of Quantitative Detection Of HBsAg And HBeAg For HBeAg Seroconversion In CHB Patients Treated With PegIFN Alpha-2a
52.	Effects Of Chronic Hepatitis B Patients With Nucleos(t)ide Analogues Treatment
53.	Intestinal Microbiota Signature Associated With HBeAg Seroconversion After Oral Antiviral Therapy
54.	Analysis On Influencing Factors Of Seroconversion And Risk Prediction Model Establishment Among HIV Serodiscordant Couples In Xinjiang
55.	Combination Treatment Of Regimens Based On Peg-interferon Fou HBe Antigen Negative Chronic Hepatitis B Focusing On Hepatitis B Suiface Antigen Clearance Or Seroconversion:A Meta-analysis
56.	Multi-Omics Characteristics Of Intestinal Microbiota Signature Associated With HBeAg Seroconversion
57.	Recombinant HBsAg vaccine in persons with HIV: Is seroconversion sufficient for long-term protection
58.	Trends in cancer and development of AIDS in HIV-infected individuals before and after implementation of highly active antiretroviral therapy
59.	Risk factors for Q-fever seroconversion in a cohort of veterinary medical students: a comparative study
60.	Effect Of Baihuaxianglian Jiedu Granule On Serological Conversion Of HBeAg And Treg/Th17 Balance Axis In Patients With Chronic Hepatitis B
<<First <Prev Next> Last>> Jump to